Forthright, first of all, calm down.....second of all,
Idon't know you from a hole in the wall, so I will not
comment on your level of expertise.Third of all, Do you
not believe for a moment that pher02, if approved,
wouldn't have a signficant impact on all those who need
blood products but have no safe access to them? You are
trying to tell me that if large pharma firms will go
after little guys like Somatogen or Alliance, trying to
get a toe hold into the multi-billion transfusion market,
that they won't race to pick Sanguine up if they show
promising animal trials on top of previous data
suggesting efficacy and safety in humans (as Fluosol,
which, remember, has the same active molecule as pher02)
? Please do not insult my intelligence and that of
others on the thread....ultimate approval has nothing to
do with a company being interested in this product; if
that were the case, why would other companies have
bothered with Somatogen and Alliance PRIOR TO PHASE TWO
trials.......only to have these products crap out......
Ladies
and gents, understand that I am not here to hype this
stock. All you need do is look at previous postings of
mine. I am here to post DD and translate medicalese into
English...... of course I will not be sitting here for
years "promoting" and waiting for ultimate approval, for
I have a job and a life. I will recoup my investment and
let the rest sit until the fundamentals
change...Forthright , you may believe what you wish, but
show a bit more respect to the longs on the thread. I
believe that I have earned it.You always have the option
of not investing in this company, but naturally you would
rather stir up trouble.BTW, I would be more than happy to
fax a copy of my degree, residency diploma and business
card to anyone who would like to see my credentials.
|
